We work with AI subject matter experts in life sciences, key opinion leaders & innovative companies and teams to reach Healthcare Innovation in Europe and China.
One of our focuses is drug development, which includes the discovery of new active ingredients. With new AI methods, costs are reduced to an unlikely extent with a very low probability of failure in clinical trials. With the help of AI, combinations of drugs data and other clinical or scientific data are calculated to identify new potential candidates.
Other applications include the use of AI to analyse molecular and clinical data of patients against global medical and pharmacological science data to improve the prediction of drug response, or the use of AI to generate new findings from high quality cancer research data that can lead to new therapies through remote laboratory experiments.
We assist and invest in international life science start-ups and champions who are seeking access to our network of R&D centres, hospitals and health institutions in Europe and China.